Due to scheduled maintenance work, this service will not be available from Tuesday August 23rd 06:00 pm until Wednesday August 24th 08:00 am
CEST. Apologies for the inconvenience.
Cellosaurus CEM/ara-G (CVCL_A5TX)
[Text version]
Cell line name |
CEM/ara-G
|
Accession |
CVCL_A5TX
|
Resource Identification Initiative |
To cite this cell line use: CEM/ara-G (RRID:CVCL_A5TX) |
Comments |
Population: Caucasian. Doubling time: 21.4 hours (PubMed=25070259). Selected for resistance to: ChEBI; CHEBI:73141; 9-beta-D-arabinofuranosylguanine (ara-G). Derived from sampling site: Peripheral blood. Cell type=T-cell.
|
Sequence variations |
- Gene fusion; HGNC; 13222; BCL11B + HGNC; 2488; NKX2-5; Name(s)=NKX2.5-BCL11B (from parent cell line).
- Mutation; HGNC; 16712; FBXW7; Simple; p.Arg465Cys (c.1393C>T); ClinVar=VCV000376414; Zygosity=Heterozygous (from parent cell line).
- Mutation; HGNC; 3765; FLT3; Simple; p.Ala627Thr (c.1879G>A); Zygosity=Heterozygous (from parent cell line).
- Mutation; HGNC; 6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
- Mutation; HGNC; 7881; NOTCH1; Simple; p.Leu1593_Arg1594insProArgLeuProHisAsnSerSerPheHisPheLeu (c.4780_4781ins36); Zygosity=Heterozygous (from parent cell line).
- Mutation; HGNC; 7881; NOTCH1; Simple; p.Pro2412Thr (c.7234C>A); Zygosity=Heterozygous (from parent cell line).
- Mutation; HGNC; 11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Heterozygous (from parent cell line).
- Mutation; HGNC; 11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Heterozygous (from parent cell line).
|
Disease |
Childhood T acute lymphoblastic leukemia (NCIt: C7953) Precursor T-cell acute lymphoblastic leukemia (ORDO: Orphanet_99861)
|
Species of origin |
Homo sapiens (Human)
(NCBI Taxonomy: 9606)
|
Hierarchy |
Parent: CVCL_0207 (CCRF-CEM)
|
Sex of cell |
Female
|
Age at sampling |
3Y11M
|
Category |
Cancer cell line
|
Publications | PubMed=25070259; DOI=10.1186/1471-2407-14-547 Yamauchi T., Uzui K., Nishi R., Shigemi H., Ueda T. Reduced drug incorporation into DNA and antiapoptosis as the crucial mechanisms of resistance in a novel nelarabine-resistant cell line. BMC Cancer 14:547.1-547.9(2014) |
Cross-references |
Encyclopedic resources |
Wikidata; Q107114639
|
Entry history |
Entry creation | 20-May-2021 |
Last entry update | 23-Jun-2022 |
Version number | 3 |
---|